Stock WINT WINDTREE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Market Closed - Nasdaq
Other stock markets
 02:00:01 04/05/2024 am IST 		5-day change 1st Jan Change
4.94 USD +14.09% Intraday chart for Windtree Therapeutics, Inc. -5.54% -61.83%
16/04 Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
11/04 North American Morning Briefing : Stock Futures -2- DJ

Evolution of the average Target Price on Windtree Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

16.wflYcKyAtXslrptVg1nvFNPHtTtnvXOQBJMw2HZ8oQQ.ssETOYG00U9kmP4N3AGwWomr-AIs1wXmMtBRiR4O8VCQgBw_w8TbTmfmzg~8e8c12d8364e94347fbff5c11776729a

Analyst Recommendations on Windtree Therapeutics, Inc.

WINDTREE THERAPEUTICS : Oppenheimer Starts Windtree Therapeutics at Outperform with $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.94 USD
Average target price
18 USD
Spread / Average Target
+264.37%
High Price Target
18 USD
Spread / Highest target
+264.37%
Low Price Target
18 USD
Spread / Lowest Target
+264.37%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Windtree Therapeutics, Inc.

Oppenheimer

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. WINT Stock
  4. Consensus Windtree Therapeutics, Inc.